Background: Retrospective study of the Salmonella sp. strains and human salmonellosis episodes registered in the Public Health Laboratory of the Principado de Asturias, Spain, over the seven year period 1990-1996.
Material And Methods: All strains were serotyped; strains of serotypes Typhi and Typhimurium were also phage typed. The strains were grouped according to: sample of origin, age group; season of the year; time distribution, and epidemiological presentation (sporadic episode or outbreak).
Results And Discussion: A total of 3,255 Salmonella isolates were registered and conserved in the period under study. They were adscribed to 45 serotypes, being Enteritidis, Typhimurium, Virchow and Hadar (57.1, 26.6, 4.5 and 2%, respectively) the most frequent. 3,193 isolates were collected from clinical samples (corresponding to 3,067 patients), 32 from environmental water or sewage, 28 from food and 2 from animal stools. Relevant epidemiological findings were: the most affected age group was children under 4 years old (32.3%), the season with highest incidence was the summer. The most frequent clinical presentation was the sporadic episode of gastroenteritis (97%). Seventy five outbreaks (22 communitary and 53 family) were registered, being associated with six serotypes: Enteritidis (76%), Typhimurium, Virchow, Hadar, Infantis and Coehl.
Download full-text PDF |
Source |
---|
Aims: The Peri-Implant and PeriProsthetic Survival AnalysiS (PIPPAS) study aimed to investigate the risk factors for one-year mortality of femoral peri-implant fractures (FPIFs).
Methods: This prospective, multicentre, observational study involved 440 FPIF patients with a minimum one-year follow-up. Data on demographics, clinical features, fracture characteristics, management, and mortality rates were collected and analyzed using both univariate and multivariate analyses.
Purpose: Neoadjuvant immune checkpoint blockade with nivolumab plus ipilimumab improves overall survival (OS) in non-small cell lung cancer (NSCLC); however, randomized data for resectable lung cancer are limited. We report results from the exploratory concurrently randomized nivolumab plus ipilimumab and chemotherapy arms of the international phase III CheckMate 816 trial.
Methods: Adults with stage IB-IIIA (American Joint Committee on Cancer seventh edition) resectable NSCLC received three cycles of nivolumab once every 2 weeks plus one cycle of ipilimumab or three cycles of chemotherapy (on day 1 or days 1 and 8 of each 3-week cycle) followed by surgery.
J Scleroderma Relat Disord
January 2025
Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
Objectives: To evaluate (1) the association between nailfold capillaroscopy pattern and 5-year risk for incident interstitial lung disease and (2) the association between transition in nailfold capillaroscopy pattern and risk of incident interstitial lung disease.
Methods: Data of adult patients from the EUSTAR database fulfilling the ACR-EULAR criteria with a disease duration ⩽5 years, having a scleroderma pattern at nailfold capillaroscopy with high-resolution computed tomography confirmed absence of interstitial lung disease (i.e.
Background: Antidepressant drug treatment may be associated with weight gain, but long-term studies are lacking.
Methods: We included 3,127 adults (1,701 women) from the REGICOR study, aged 55.6 (SD = 11.
Surg Neurol Int
December 2024
Department of Neurosurgery, Fundación Clínica Shaio, Bogotá, Colombia.
Background: Impulsive aggression is the core symptom of intermittent explosive disorder, which can be a feature of several psychiatric disorders. There is a subset of individuals who do not respond adequately to medical treatment; they are treatment refractory. The objective of this report is to describe a case of a patient with a background of schizophrenia and concomitant refractory aggressiveness disorder, treated with two-stage bilateral hypothalamotomy and unilateral amygdalotomy with Gamma Knife radiosurgery (GKR).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!